Compound overview · Research
What Is Selank? Structure, Mechanism & Research Overview
What is Selank? A synthetic seven-amino-acid peptide built on the immune peptide tuftsin. This overview covers its structure, the mechanisms proposed in published research, the main animal and cell studies, and how researchers handle it in the lab.
Key takeaways
- Selank is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP), a stabilised analogue of tuftsin.
- Published research links it to GABA-A receptor modulation, enkephalinase inhibition and BDNF expression, mostly in rodent models.
- It was developed at the Institute of Molecular Genetics in Moscow; it is not approved by the EMA or FDA.
- Identity is confirmed by mass spectrometry at about 751.9 Da.
What is Selank?
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Its first four residues are tuftsin, a natural tetrapeptide cleaved from immunoglobulin G. Tuftsin itself breaks down within minutes, so researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences added a C-terminal Pro-Gly-Pro tail to slow enzymatic degradation. The result is a peptide studied for both neuroactive and immune-related effects.
Research use only. This overview summarises published laboratory and animal research. Baltic Peptides supplies this compound for in-vitro and preclinical research by qualified researchers; it is not a medicine and is not for human or veterinary use.
Structure and specifications
| Property | Value |
|---|---|
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP) |
| Length | 7 amino acids |
| Molecular formula | C33H57N11O9 |
| Molecular weight | ≈751.9 g/mol |
| CAS number | 129954-34-3 |
| Parent peptide | Tuftsin (Thr-Lys-Pro-Arg) |
| Related compound | N-Acetyl Selank Amidate |
The Pro-Gly-Pro motif is also found in Semax, where it plays the same stabilising role. On a COA, identity should be confirmed by a mass spectrometry result close to 751.9 Da; see HPLC peptide testing explained for how purity is measured.
Mechanisms proposed in published research
GABAergic modulation
The most-cited mechanism is an effect on the GABA system. In a rat study, Volkova et al. (2016) found that Selank changed the expression of a set of genes involved in GABAergic neurotransmission in the frontal cortex, and the authors compared the pattern with that of GABA and GABA-A modulators. Other work describes concentration-dependent effects on GABA binding at a site distinct from the benzodiazepine site.
Enkephalin degradation
Earlier studies reported that Selank inhibits enkephalin-degrading enzymes, which would prolong the action of endogenous enkephalins. This is one of the proposed explanations for behavioural effects seen in anxiety-related rodent models.
Neurotrophins and immune signalling
Rodent studies have also reported changes in hippocampal BDNF expression, and, consistent with its tuftsin origin, effects on cytokine expression. Kozlovskaya et al. (2003) review Selank alongside other short tuftsin-family peptides.
Main research areas
- Anxiety and stress models in rodents, often compared with benzodiazepine reference compounds.
- Learning and memory paradigms, linked to the reported BDNF effects.
- Neuro-immune interaction: cytokine and gene-expression profiling, building on tuftsin biology.
- Peptide stability: Selank is a reference example of extending a short peptide’s half-life with a C-terminal motif.
Much of the primary literature was published in Russian-language journals; English-language abstracts are indexed on PubMed for many of them.
Selank vs. Semax
| Selank | Semax | |
|---|---|---|
| Parent peptide | Tuftsin (IgG fragment) | ACTH(4-10) |
| Sequence | TKPRPGP | MEHFPGP |
| Stabilising motif | Pro-Gly-Pro | Pro-Gly-Pro |
| Main research focus | GABAergic and anxiety models | BDNF/TrkB and neuroprotection models |
Both were developed in Moscow and are frequently studied side by side. Read our overview of what Semax is for the comparison in more detail.
Handling Selank in the lab
Selank is supplied lyophilised (or as a crystalline solid) and is most stable kept dry, sealed and cold. Standard laboratory practice: store long-term at -20 °C, protect from light and moisture, let vials reach room temperature before opening, and prepare solutions fresh in sterile water or buffer. See our guide to storing peptides in the lab for the full routine, and our COA reading guide for how to check the batch report.
Selank for research in Europe
Baltic Peptides ships Selank from Lithuania with tracked delivery across the EU, so orders to Germany, France, the Netherlands, Poland, the Nordics and the Baltics stay inside one customs area. Every batch is tested by Janoshik Analytical before release and published on our COA page. View the Selank product page for current batches and formats, or see EU shipping for delivery times.
Sources and further reading
- Volkova A. et al. (2016). Selank administration affects the expression of some genes involved in GABAergic neurotransmission. Front Pharmacol. PubMed
- Kozlovskaya M.M. et al. (2003). Selank and short peptides of the tuftsin family. Eksp Klin Farmakol. PubMed
- Selank (Wikipedia overview).
All Baltic Peptides products are supplied strictly for laboratory research use. They are not medicines, supplements or food and are not for human or animal use. This article explains analytical testing and is for educational purposes only.
FAQ
Common questions
What is Selank?
What is the molecular weight of Selank?
How is Selank different from tuftsin?
Is Selank approved in the EU?
Where can I see a Selank batch report?
Keep reading
Related reading
Selank
Current batches, formats and the COA for Selank.
How to read a peptide COA
The 9-step checklist for any certificate of analysis.
How to store peptides in the lab
Storage and handling for lyophilised research compounds.
Research-grade Selank, tested before it ships
Independent HPLC and mass spec results for every batch, dispatched from the EU.
